SBI Pharma Fund - Direct (D)

Fund Class : Equity - Pharma
Fund House : SBI Mutual Fund
Aum(Rs Cr) : 65.14
NAV 27 Mar 2017 117.34 -1.46
(-1.23%)

NAV High-Low (in Rs)

ONE Mth
52-WEEk 997.38
1086.94

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes - - - 1.02 21.73
Sensex -0.26 2.32 3.95 17.8 31.65
Nifty -0.23 2.49 4.07 19.51 35.92

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 65.14 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Tanmaya Desai

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 28 Feb 2017
Category Share (%)
Cash & Bank Balance & Bank Deposits 0.01
CBLO 2.30
Equity 97.01
Foreign Equity 1.11
› More
   As On 28 Feb 2017
Sector Name Amount
Healthcare 4.95
Miscellaneous 4.00
NA 2.31
Pharmaceuticals 1.11
Pharmaceuticals - Indian - Bulk Drugs 17.51
Pharmaceuticals - Indian - Bulk Drugs & Formln 62.84
Pharmaceuticals - Indian - Formulations 5.36
Pharmaceuticals - Multinational 2.35
› More
   As On 28 Feb 2017
Company Name
Sun Pharma.Inds. 15.51
Strides Shasun 9.96
Aurobindo Pharma 9.03
Cipla 8.89
Lupin 8.42
Glenmark Pharma. 6.17
Alkem Lab 4.08
Thyrocare Tech. 4.00
› More

Fund DETAILS

Asset Management Co.

Registered Address

SBI Funds Management Ltd,

9th floorCrescenzoC-39&39
G BlockBandra-kurla complex
Bandra (east)Mumbai-400 051.

Phone: 022-61793000 | Fax: 022-2218 9663

Email: partnerforlife@sbimf.com

Website: www.sbimf.com